Rakesh Jhunjhunwala Portfolio Update For 2018
Calendar 2017 has been particularly good for Rakesh Jhunjhunwala as one-third of his portfolio stocks doubled in value, while half of them delivered returns in excess of two times that of the BSE Sensex.
The 30-pack BSE Sensex rose 26 per cent. Rakesh Jhunjhunwala’s portfolio stocks have gained up to 280 per cent.
RECENT INVESTMENTS
Rakesh Jhunjhunwala is the largest individual investor on Dalal Street with $3.2 billion wealth, whose investments in just 10 stocks are worth over Rs 9,200 crore, made news this year by investing in stocks of Fortis Healthcare, Prakash Industries and JP Associates, companies either crippled by huge debt pile or regulatory surveillance.
Prakash Industries was named among the 331 suspected 'shell' companies against whom markets regulator Sebi had initiated a trading ban. The Securities Appellate Tribunal (SAT) later lifted the curb.
Fortis Healthcare's Singh brothers and Daiichi are locked in litigation over claims of Rs 3,500 crore in damages and interest by the latter. JP Associates is struggling with huge debt on its balance sheet.
Jhunjhunwala recently acquired a stake in gaming company Nazara Technologies for Rs 180 crore in his first ever bet on the digital space.
His wife Rekha Jhunjhunwala was seen selling shares in Delta Corp.
BEST PERFORMING STOCKS
Among the 30-odd listed firms where Jhunjhunwala owns over 1 per cent stake, Prakash Industries has seen its shares rise 277 per cent.
Geojit BNP Paribas is another stock in his portfolio, which has delivered a staggering 206 per cent return this calendar. Shares of another brokerage, Edelweiss Securities, have risen 198 per cent. Jhunjhunwala owns 1.05 per cent stake in this broking firm, which has just acquired the broking business of Religare Enterprises.
Baggage maker VIP Industries rewarded Jhunjhunwala with 206 per cent return.
Shares of Titan Company, jewel of the Jhunjhunwala portfolio, have risen 165 per cent this calendar. Titan has been his preferred pick. The ace investor and his better half Rekha Jhunjhunwala together hold 8.06 per cent stake in the company, which was worth Rs 6,182 crore as of Wednesday.
Escorts, Aptech, Autoline, ION Exchange are some other stocks in the Jhunjhunwala portfolio that delivered over 100 per cent return in 2017.
SEPT QUARTER REJIG IN PORTFOLIO
September quarter shareholding data showed Jhunjhunwala sequentially trimmed his stake in Titan Company, Aurobindo Pharma, TV18 Broadcast, Jubilant Life Sciences, Federal Bank and JP Associates, among others, even as it raises his stakes in Karur Vysya Bank and Prakash Industries.
RJ and his better half together held 7,15,86,220 shares, or 8.06 per cent stake in Titan Company at the end of September quarter, 20 basis points lower than their total holding at the end of June quarter. The ace investor had 1.12 per cent stake in Aurobindo Pharma as of June 30, which came down below 1 per cent, a minimum threshold that requires companies to name investors in shareholding data. JP Associates is another stock where Jhunjhuwala had just above 1 per cent stake (1.03 per cent) as of June 30. His name did not figure in September shareholding data.
Rekha Jhunjhunwala held 2,37,86,700 shares comprising a 1.39 per cent stake in TV18 Broadcast at the end of September quarter down from 2,47,86,700 shares, or 1.45 per cent stake, she held at the end of June quarter.
September quarter data had no mention of Rakesh Jhunjhunwala's stake in TV18. The ace investor held 1,97,73,300 shares, or 1.15 per cent stake, in the company at the end of June.